More Detailed Information
Scientific principles underlying EECP
EECP therapy is based on several scientific principles that underlie its mechanism of action and therapeutic effects. Some of the key scientific principles underlying EECP therapy include:
- Counterpulsation: EECP therapy operates on the principle of counterpulsation, which involves applying external pressure to the lower extremities during diastole, the resting phase of the cardiac cycle. By inflating cuffs around the calves, thighs, and buttocks in synchrony with the patient’s heartbeat, EECP creates a counterpulsation effect that enhances blood flow to the heart.
- Diastolic Augmentation: During diastole, the heart relaxes and fills with blood from the coronary arteries. By enhancing blood flow to the heart during this phase, EECP therapy increases coronary artery perfusion, delivering oxygen-rich blood to the myocardium (heart muscle) and improving myocardial oxygen supply.
- Shear Stress and Endothelial Function: EECP therapy generates shear stress on the endothelial lining of blood vessels, which stimulates the release of nitric oxide and other vasodilators. These vasodilators help to relax and dilate blood vessels, improving vascular function and promoting blood flow throughout the body.
- Peripheral Vasodilation: EECP therapy induces peripheral vasodilation, which helps to reduce peripheral vascular resistance and improve systemic circulation. This can have beneficial effects on conditions such as peripheral artery disease, hypertension, and erectile dysfunction.
- Enhanced Venous Return: By compressing the veins in the lower extremities, EECP therapy promotes venous return to the heart, increasing preload and stroke volume. This can improve cardiac output and overall haemodynamic function, particularly in patients with heart failure or reduced cardiac function.
- Neurohormonal Regulation: EECP therapy may modulate neurohormonal pathways involved in cardiovascular regulation, including the sympathetic nervous system and the renin-angiotensin-aldosterone system. These effects can help to reduce cardiac workload, lower blood pressure, and improve cardiovascular function.
- Angiogenesis and Collateral Formation: Enhanced External Counterpulsation, has been associated with changes in Vascular Endothelial Growth Factor (VEGF) levels in some studies. VEGF is a protein that plays a crucial role in angiogenesis, the process of forming new blood vessels from pre-existing ones. EECP treatment is believed to stimulate the release of growth factors, including VEGF, as part of its mechanism of action. Increased levels of VEGF may contribute to the formation of new blood vessels (angiogenesis) and the development of collateral circulation, which can enhance blood flow to ischemic tissues, such as those affected by coronary artery disease. This process can enhance blood flow to areas of the heart that may have poor perfusion due to coronary artery disease, thereby improving oxygen delivery to ischemic tissue and reducing angina symptoms.
EECP therapy operates on several scientific principles, including counterpulsation, diastolic augmentation, endothelial function, peripheral vasodilation, enhanced venous return, and neurohormonal regulation. These mechanisms contribute to the therapeutic effects of EECP therapy, including improved symptoms, exercise tolerance, and quality of life in patients with various cardiovascular conditions.